MolMed 06
IPO e altre ammissioni - 2008 - Borsa Italiana
Azioni Molecular Medicine in Borsa | Quotazione F: 4HW - Investing.com
1 - [Note: this notice is the English translation of the official version of the 102 notice which will be in Italian language]
OFFERTE PUBBLICHE DI ACQUISTO
Relazione sulla remunerazione Molecular Medicine S.p.A.
MolMed: il modello vincente della biotech italiana - AboutPharma
MolMed now part of AGC Biologics | Iterate.ai
Azioni Mutuionline: quotazioni in tempo reale | IT0004195308 - Borsa Italiana
Relazione sulla Remunerazione MolMed S.p.A.
MolMed - YouTube
COMUNICATO STAMPA
Will MolMed soon have its first Cell therapy on the Market?
Overview of the Italian Primary Markets
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER
Will MolMed soon have its first Cell therapy on the Market?
MolMed now part of AGC Biologics | Iterate.ai
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER
Molmed trema, opa giapponese in bilico per golden power - Il Sole 24 ORE
MolMed: Contact Details and Business Profile
MOLMED S.P.A.: MLM Azione Prezzo| IT0001080248 | MarketScreener
Calendario semestrali società Borsa Italiana: conti primo semestre in uscita a luglio e agosto 2018
MolMed now part of AGC Biologics | LinkedIn
MOLMED S.P.A. : MLM Stock Price | IT0001080248 | MarketScreener
Molmed verso delisting. Successo dell'OPA promossa da AGC
MolMed - Wikipedia
